Harvard Bioscience Gross Margin 2012-2026 | HBIO
Current and historical gross margin for Harvard Bioscience (HBIO) over the last 10 years. The current gross profit margin for Harvard Bioscience as of March 31, 2026 is %.
| Harvard Bioscience Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.09B | $0.05B | 58.14% |
| 2025-12-31 | $0.09B | $0.05B | 57.47% |
| 2025-09-30 | $0.09B | $0.05B | 56.82% |
| 2025-06-30 | $0.09B | $0.05B | 57.30% |
| 2025-03-31 | $0.09B | $0.05B | 56.52% |
| 2024-12-31 | $0.10B | $0.06B | 57.89% |
| 2024-09-30 | $0.10B | $0.06B | 58.16% |
| 2024-06-30 | $0.10B | $0.06B | 58.42% |
| 2024-03-31 | $0.11B | $0.06B | 58.88% |
| 2023-12-31 | $0.11B | $0.07B | 58.93% |
| 2023-09-30 | $0.11B | $0.07B | 58.93% |
| 2023-06-30 | $0.11B | $0.06B | 55.26% |
| 2023-03-31 | $0.11B | $0.06B | 55.26% |
| 2022-12-31 | $0.11B | $0.06B | 53.98% |
| 2022-09-30 | $0.12B | $0.07B | 55.08% |
| 2022-06-30 | $0.12B | $0.07B | 57.02% |
| 2022-03-31 | $0.12B | $0.07B | 56.20% |
| 2021-12-31 | $0.12B | $0.07B | 56.30% |
| 2021-09-30 | $0.12B | $0.07B | 55.56% |
| 2021-06-30 | $0.11B | $0.06B | 55.86% |
| 2021-03-31 | $0.11B | $0.06B | 57.14% |
| 2020-12-31 | $0.10B | $0.06B | 56.86% |
| 2020-09-30 | $0.10B | $0.06B | 55.88% |
| 2020-06-30 | $0.11B | $0.06B | 56.19% |
| 2020-03-31 | $0.11B | $0.06B | 54.46% |
| 2019-12-31 | $0.12B | $0.06B | 55.17% |
| 2019-09-30 | $0.12B | $0.07B | 55.46% |
| 2019-06-30 | $0.12B | $0.07B | 55.37% |
| 2019-03-31 | $0.12B | $0.07B | 53.66% |
| 2018-12-31 | $0.12B | $0.06B | 51.64% |
| 2018-09-30 | $0.11B | $0.06B | 50.00% |
| 2018-06-30 | $0.10B | $0.05B | 49.00% |
| 2018-03-31 | $0.09B | $0.04B | 49.43% |
| 2017-12-31 | $0.08B | $0.04B | 51.28% |
| 2017-09-30 | $0.08B | $0.04B | 50.00% |
| 2017-06-30 | $0.09B | $0.04B | 48.86% |
| 2017-03-31 | $0.10B | $0.05B | 48.42% |
| 2016-12-31 | $0.10B | $0.05B | 47.12% |
| 2016-09-30 | $0.11B | $0.05B | 47.17% |
| 2016-06-30 | $0.11B | $0.05B | 46.73% |
| 2016-03-31 | $0.11B | $0.05B | 46.36% |
| 2015-12-31 | $0.11B | $0.05B | 44.95% |
| 2015-09-30 | $0.11B | $0.05B | 45.05% |
| 2015-06-30 | $0.11B | $0.05B | 44.55% |
| 2015-03-31 | $0.11B | $0.05B | 44.44% |
| 2014-12-31 | $0.11B | $0.05B | 45.37% |
| 2014-09-30 | $0.11B | $0.05B | 44.34% |
| 2014-06-30 | $0.11B | $0.05B | 44.34% |
| 2014-03-31 | $0.11B | $0.05B | 44.76% |
| 2013-12-31 | $0.11B | $0.05B | 44.76% |
| 2013-09-30 | $0.11B | $0.05B | 45.71% |
| 2013-06-30 | $0.11B | $0.05B | 46.23% |
| 2013-03-31 | $0.11B | $0.05B | 47.22% |
| 2012-12-31 | $0.11B | $0.05B | 47.27% |
| 2012-09-30 | $0.11B | $0.05B | 46.85% |
| 2012-06-30 | $0.11B | $0.05B | 46.85% |
| 2012-03-31 | $0.11B | $0.05B | 46.36% |
| 2011-12-31 | $0.11B | $0.05B | 46.30% |
| 2011-09-30 | $0.11B | $0.05B | 46.79% |
| 2011-06-30 | $0.11B | $0.05B | 47.71% |
| 2011-03-31 | $0.11B | $0.05B | 47.22% |
| 2010-12-31 | $0.11B | $0.05B | 48.15% |
| 2010-09-30 | $0.11B | $0.05B | 48.11% |
| 2010-06-30 | $0.10B | $0.05B | 47.52% |
| 2010-03-31 | $0.09B | $0.05B | 48.39% |
| 2009-12-31 | $0.09B | $0.04B | 47.67% |
| 2009-09-30 | $0.08B | $0.04B | 49.38% |
| 2009-06-30 | $0.08B | $0.04B | 48.75% |
| 2009-03-31 | $0.09B | $0.04B | 48.24% |
| 2008-12-31 | $0.09B | $0.04B | 47.73% |
| 2008-09-30 | $0.09B | $0.04B | 46.67% |
| 2008-06-30 | $0.09B | $0.04B | 47.19% |
| 2008-03-31 | $0.09B | $0.04B | 47.67% |
| 2007-12-31 | $0.08B | $0.04B | 48.19% |
| 2007-09-30 | $0.08B | $0.04B | 48.75% |
| 2007-06-30 | $0.08B | $0.04B | 48.75% |
| 2007-03-31 | $0.08B | $0.04B | 48.72% |
| 2006-12-31 | $0.08B | $0.04B | 50.00% |
| 2006-09-30 | $0.07B | $0.04B | 50.00% |
| 2006-06-30 | $0.07B | $0.04B | 51.43% |
| 2006-03-31 | $0.07B | $0.04B | 51.47% |
| 2005-12-31 | $0.07B | $0.03B | 50.75% |
| 2005-09-30 | $0.05B | $0.03B | 50.94% |
| 2005-06-30 | $0.05B | $0.03B | 49.06% |
| 2005-03-31 | $0.06B | $0.03B | 49.15% |
| 2004-12-31 | $0.07B | $0.03B | 49.23% |
| 2004-09-30 | $0.09B | $0.04B | 49.41% |
| 2004-06-30 | $0.09B | $0.04B | 49.44% |
| 2004-03-31 | $0.09B | $0.04B | 49.44% |
| 2003-12-31 | $0.09B | $0.04B | 50.00% |
| 2003-09-30 | $0.08B | $0.04B | 49.38% |
| 2003-06-30 | $0.07B | $0.04B | 49.32% |
| 2003-03-31 | $0.07B | $0.03B | 49.23% |
| 2002-12-31 | $0.06B | $0.03B | 48.28% |
| 2002-09-30 | $0.05B | $0.03B | 49.02% |
| 2002-06-30 | $0.05B | $0.02B | 48.98% |
| 2002-03-31 | $0.05B | $0.02B | 48.89% |
| 2001-12-31 | $0.04B | $0.02B | 47.62% |
| 2001-09-30 | $0.04B | $0.02B | 46.15% |
| 2001-06-30 | $0.04B | $0.02B | 47.22% |
| 2001-03-31 | $0.03B | $0.02B | 48.48% |
| 2000-12-31 | $0.03B | $0.02B | 48.39% |
| 2000-09-30 | $0.03B | $0.02B | 63.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |